The CRP genotype, serum levels and lung function in men: The caerphilly prospective study

Clinical Science

Volumn 120, Issue 8, 2011, Pages 347-355

  Bolton, Charlotte E ^a,b   Schumacher, Wiebke ^c   Cockcroft, John R ^a   Timpson, Nicholas J ^c   Smith, George Davey ^c   Gallacher, John ^d   Rumley, Anne ^e   Lowe, Gordon D ^e   Ebrahim, Shah ^f   Shale, Dennis J ^a   Ben Shlomo, Yoav ^c  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e GLASGOW ROYAL INFIRMARY   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

C reactive protein; Forced expiratory volume in 1 s (FEV1); Lung function; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENOTYPE; HAPLOTYPE; HUMAN; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CONFOUNDING FACTORS (EPIDEMIOLOGY); FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; LUNG; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SPIROMETRY; VITAL CAPACITY;

EID: 79951792501     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100504     Document Type: Article

References (35)

1. Shaaban, R., Kony, S., Driss, F., Leynaert, B., Soussan, D., Pin, I., Neukirch, F. and Zureik, M. (2006) Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir. Med. 100, 2112-2120
2. Fogarty, A. W., Jones, S., Britton, J. R., Lewis, S. A. and McKeever, T. M. (2007) Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 62, 515-520
3. Gan, W. Q., Man, S. F., Senthilselvan, A. and Sin, D. D. (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59, 574-580
4. Eid, A. A., Ionescu, A. A., Nixon, L. S., Lewis-Jenkins, V., Matthews, S. B., Griffiths, T. L. and Shale, D. J. (2001) Inflammatory response and body composition in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164, 1414-1418
5. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. and Hennekens, C. H. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336, 973-979
6. Mendall, M. A., Strachan, D. P., Butland, B. K., Ballam, L., Morris, J., Sweetnam, P. M. and Elwood, P. C. (2000) C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur. Heart J. 21, 1584-1590
7. Sin, D. D.,Wu, L. and Man, S. F. (2005) The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127, 1952-1959
8. Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, Jr, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G. et al. (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195-2207
9. Zacho, J., Tybjærg-Hansen, A., Skov Jensen, J., Grande, P., Sillesen, H. and Nordestgaard, B. G. (2008) Genetically elevated C-reactive protein and ischemic vascular disease. N. Eng. J. Med. 359, 1897-1908
10. Timpson, N. J., Lawlor, D. A., Harbord, R. M., Gaunt, T. R., Day, I. N., Palmer, L. J., Hattersley, A. T., Ebrahim, S., Lowe, G. D., Rumley, A. and Davey Smith, G. (2005) C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet 366, 1954-1959 (Pubitemid 41713985)
11. Carlson, C. S., Aldred, S. F., Lee, P. K., Tracy, R. P., Schwartz, S. M., Rieder, M., Liu, K., Williams, O. D., Iribarren, C., Lewis, E. C. et al. (2005) Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am. J. Hum. Genet. 77, 64-77
12. Davey Smith, G. and Ebrahim, S. (2003) 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 32, 1-22
13. Davey Smith, G. and Ebrahim, S. (2005) What can Mendelian randomisation tell us about modifiable behavioural and environmental exposures. Br. Med. J. 330, 1076-1079
14. Sunyer, J., Pistelli, R., Plana, E., Andreani, M., Baldari, F., Kolz, M., Koenig, W., Pekkanen, J., Peters, A. and Forastiere, F. (2008) Systemic inflammation, genetic susceptibility and lung function. Eur. Respir. J. 32, 92-97
15. Yanbaeva, D. G., Dentener, M. A., Spruit, M. A., Houwing-Duistermaat, J. J., Kotz, D., Passos, V. L. and Wouters, E. F. (2009) IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. BMC Med. Genet. 10, 23
16. van Durme, Y. M., Verhamme, K. M., Aarnoudse, A. J., Van Pottelberge, G. R., Hofman, A., Witteman, J. C., Joos, G. F., Brusselle, G. G. and Stricker, B. H. (2009) C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 179, 375-382
17. The Caerphilly and Speedwell Collaborative Group Caerphilly and Speedwell collaborative heart disease studies (1984) J. Epidemiol. Community Health 38, 259-262
18. Emerging Risk Factors Collaboration, Kaptoge, S., Di Angelantonio, E., Lowe, G., Pepys, M. B., Thompson, S. G., Collins, R. and Danesh, J. (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375, 132-40
19. Russell, A. I., Cunninghame Graham, D. S., Shepherd, C., Roberton, C. A., Whittaker, J, Meeks, J., Powell, R. J., Isenberg, D. A., Walport, M. J. and Vyse, T. J. (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum. Mol. Genet. 13, 137-147
20. Suk, H. J., Ridker, P. M., Cook, N. R. and Zee, R. Y. (2005) Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178, 139-145
21. Zee, R. Y. and Ridker, P. M. (2002) Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162, 217-219
22. Excoffier, L. and Slatkin, M. (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol. 12, 921-927
23. Schumacher, W., Cockcroft, J., Timpson, N. J., McEniery, C. M., Gallacher, J., Rumley, A., Lowe, G., Smith, G. D., Wilkinson, I. B. and Ben-Shlomo, Y. (2009) Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension 53, 150-157
24. Hage, F. G. and Szalai, A. J. (2007) C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J. Am. Coll. Cardiol. 50, 1115-1122
25. Kony, S., Zureik, M., Driss, F., Neukirch, C., Leynaert, B. and Neukirch, F. (2004) Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 59, 892-896 (Pubitemid 39389631)
26. Aronson, D., Roterman, I., Yigla, M., Kerner, A., Avizohar, O., Sella, R., Bartha, P., Levy, Y. and Markiewicz, W. (2006) Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am. J. Respir. Crit. Care Med. 174, 626-632
27. Davey Smith, G., Lawlor, D. A., Harbord, R., Timpson, N., Rumley, A., Lowe, G. D., Day, I. N. and Ebrahim, S. (2005) Association of C-reactive protein with blood pressure and hypertension: life course confounding and Mendelian randomization tests of causality. Arterioscler. Thromb. Vasc. Biol. 25, 1051-1056
28. Wedzicha, J. A., Seemungal, T. A., MacCallum, P. K., Paul, E. A., Donaldson, G. C., Bhowmik, A., Jeffries, D. J. and Meade, T.W. (2000) Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb. Haemostasis 84, 210-215 (Pubitemid 30601465)
29. Vernooy, J. H., Kucukaycan, M., Jacobs, J. A., Chavannes, N. H., Buurman, W. A., Dentener, M. A. and Wouters, E. F. (2002) Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am. J. Respir. Crit. Care Med. 166, 1218-1224
30. Michel, O., Dentener, M., Corazza, F., Buurman, W. and Rylander, R. (2001) Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy. J. Allergy Clin. Immunol. 107, 797-804
31. He, J. Q., Foreman, M. G., Shumansky, K., Zhang, X., Akhabir, L., Sin, D. D., Man, S. F., DeMeo, D. L., Litonjua, A. A., Silverman, E. K. et al. (2009) Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 64, 698-704
32. Lange, L. A., Carlson, C. S., Hindorff, L. A., Lange, E. M., Walston, J., Durda, J. P., Cushman, M., Bis, J. C., Zeng, D., Lin, D. et al. (2006) Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA, J. Am. Med. Assoc. 296, 2703-2711 (Pubitemid 44917547)
33. Schnabel, R., Larson, M. G., Dupuis, J., Lunetta, K. L., Lipinska, I., Meigs, J. B., Yin, X., Rong, J., Vita, J. A., Newton-Cheh, C. et al. (2008) Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension 51, 1651-1657
34. Elliott, P., Chambers, J. C., Zhang, W., Clarke, R., Hopewell, J. C., Peden, J. F., Erdmann, J., Braund, P., Engert, J. C., Bennett, D. et al. (2009) Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA, J. Am. Med. Assoc. 302, 37-48
35. Ben-Shlomo, Y. and Kuh, D. (2002) A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int. J. Epidemiol. 31, 285-293